close

Orthofix International N.V. designs, develops, manufactures, markets, and distributes medical equipment, principally for the orthopedic applications. Its products include invasive and minimally invasive spinal implant products and related human cellular and tissue based products; non-invasive bone growth stimulation products for spinal fusions and to treat non-union fractures; external and internal fixation devices used in fracture treatment, limb lengthening, and bone reconstruction; and bracing products used for ligament injury prevention, pain management, and protection of surgical repair. The company's products also comprise a device for enhancing venous circulation, cold therapy, bone cement and devices for removal of bone cement used to fix artificial implants, and airway management products used in anesthesia applications. It provides its products for the spine, orthopedics, sports medicine, and vascular market sectors serving hospitals, clinics, surgery centers, independent distributors or other healthcare providers, and patients by third-party payors. Orthofix International distributes its products in the United States, the United Kingdom, Italy, Germany, Switzerland, Austria, France, Belgium, Mexico, Brazil, and Puerto Rico through its direct sales representatives and independent distributors. The company was founded in 1979 and is based in Curacao, the Netherlands Antilles.

(login to add this stock to your watchlist or favorites)

Key Statistics

Closing Price	40.05
Volume	66336
Volume Avg	78947
52 Week High	44.57
52 Week Low	30.81
PE	N/A
PE (group average)	39
EPS Year	-0.06
EPS change Q/Q	1000%
EPS change Q/Q Yr ago	1000%
EPS change Q/Q next Q est	1000%
EPS change Y/Y	-1000%
REV change Q/Q	-3.2%
REV change Q/Q Yr ago	0.29%
EPS next Q est	0.74
EPS next Y est	3.41
Divident Annual	0.00
Dividend Yield	0%